As of 2025-09-19, the Relative Valuation of Canntab Therapeutics Ltd (PILL.CN) is (0.36) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Canntab Therapeutics Ltd based on Relative Valuation is -7257.7%.
The range of the Relative Valuation is (0.29) - (0.43) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.3x - 5.0x | 4.2x |
| Forward P/E multiples | 3.3x - 5.0x | 4.2x |
| Fair Price | (0.29) - (0.43) | (0.36) |
| Upside | -5826.2% - -8689.3% | -7257.7% |
| Date | P/E |